Efficacy of risperidone in treatment of paranoid symptoms in Alzheimer's disease (A.D.) and vascular dementia (V.D.)

Author： Wittgens W.   Klieser E.   Trenckmann U.   Beine K.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 351-351

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Risk-Benefit Assessment of Risperidone for the Treatment of Behavioural and Psychological Symptoms in Dementia

By Zaudig M.  

Drug Safety, Vol. 23, Iss. 3, 2000-09 ,pp. : 183-195

Adis International

Access to resources Recommend Favorite

Galantamine in the Treatment of Cognitive Decline in Patients with Vascular Dementia or Alzheimer’s Disease with Cerebrovascular Disease

By Small G.  

CNS Drugs, Vol. 17, Iss. 12, 2003-01 ,pp. : 905-914

Adis International

Access to resources Recommend Favorite

Risperidone for behavioural and psychological symptoms of dementia

By  

Inpharma, Vol. 1, Iss. 1361, 2002-01 ,pp. : 11-13

Adis International

Access to resources Recommend Favorite

Cerebral Arachidonate Cascade in Dementia: Alzheimer's Disease and Vascular Dementia

By  

Current Neuropharmacology, Vol. 4, Iss. 1, 2006-01 ,pp. : 87-100

Bentham Science Publishers

Access to resources Recommend Favorite

Possible Role of Vascular Risk Factors in Alzheimer's Disease and Vascular Dementia

By  

Current Pharmaceutical Design, Vol. 20, Iss. 38, 2014-11 ,pp. : 6007-6013

Bentham Science Publishers

Access to resources Recommend Favorite